HENWOOD GERALDINE 4
4 · Baudax Bio, Inc. · Filed Dec 23, 2021
Insider Transaction Report
Form 4
Baudax Bio, Inc.BXRX
HENWOOD GERALDINE
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-12-22+821,168→ 821,168 totalExercise: $1.70Exp: 2031-01-20→ Common Stock (821,168 underlying) - Tax Payment
Common Stock
2021-12-15$0.31/sh−18,636$5,777→ 336,716 total
Holdings
- 20,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F2]The Option was granted on January 20, 2021, contingent upon the Company's board of directors approval of the increase in the number of shares available for issuance under the Company's 2019 Equity Incentive Plan pursuant to the evergreen provision therein.
- [F3]The stock option vests in equal monthly installments over 48 months, beginning on February 20, 2021, subject to continued service to the Company.